Teladoc’s Outlook Clouds As JPMorgan Points To Uncertainty In Behavioral Health, Margin Pressure

All NewsMay 16, 2025

JP Morgan analyst Lisa C. Gill maintained Neutral rating on TDOC with $9 price target, down from $11. Teladoc reports Q1 revenue of $629.4M.

Latest Ratings for TDOC

DateFirmActionFromTo Mar 2022Piper SandlerMaintainsOverweight Mar 2022UBSMaintainsNeutral Mar 2022Argus ResearchUpgradesHoldBuy

View More Analyst Ratings for TDOC

View the Latest Analyst Ratings

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent